Search

Harvard Medical School’s Richard Sherwood digs into the potential and pitfalls of gene editing technology.

Marcus Horwitz’s primary focus is on infectious diseases, but a number of pathogens he has studied led him into the realm of bio-terrorism.

Sitting Down With... Bruce Levine, Professor in Cancer Gene Therapy, Perelman School of Medicine, University of Pennsylvania.

A screen of 2000 synthetic compounds has uncovered a novel agent against antiviral resistant influenza.

A new approach may hold the key to preventing deadly brain bleeds - an optical lens capable of imaging blood vessels in real time.

How DNA origami nanostructures could find their way into the treatment of acute kidney injury.

Two chemical components; opposite effects. How medical marijuana impacts glaucoma for better – and for worse.

Sitting Down With… Ingun Holen, Professor of Bone Oncology at the University of Sheffield Medical School, Sheffield, UK.

We sat down with David Eidelberg shortly after the publication of his group’s most recent paper in Science Translational Medicine.

Progress in tissue engineering may offer hope to patients suffering from debilitating intervertebral disc degeneration.